Major electrocardiogram abnormalities have been found in patients with type 2 diabetes.
Read More »Effects of Basal Insulin on Lipids vs. Other Antihyperglycemics
How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?
Read More »ADA 2021: Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose
Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.
Read More »ADA 2021: Are Patients with Obesity or Diabetes at Increased Risk for Severe COVID-19?
Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19.
Read More »Developing a T1D Prediction Model
Study finds type 1 diabetes may account for 8% of diabetes cases in young adults.
Read More »ADA 2021: A Promising Future for Tirzepatide
American Diabetes Association symposium presents new phase 3 clinical trials of SURPASS-3 and SURPASS-5.
Read More »ADA 2021: Long-term Safety of Intranasal Insulin in Insulin-Dependent Type 2 Diabetes
Researchers assess the safety of intranasal insulin as a treatment for type 2 diabetes-associated cognitive impairment in aging adult populations.
Read More »ADA 2021: Dapagliflozin Use in Patients with COVID-19
Dapagliflozin has shown clinical effectiveness in some of the same metabolic processes that are affected by COVID-19, but can it help treat patients who have contracted the virus?
Read More »ADA 2021: Risk Reduction of Type 2 Diabetes after Gestational Diabetes
The prevalence of underdiagnosed prediabetes and type 2 diabetes mellitus (T2DM) plays an active role in gestational diabetes.
Read More »ADA 2021: Infusion Set Survival and Performance of Medtronic Extended-Wear Infusion Set
Real-world data for the Medtronic Extended-Wear Infusion Set revealed at the 81st American Diabetes Association scientific session.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.